Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8850612 | 0.91 | LMNA (0.34) | LMNAHSD17B10 | |
| SCHEMBL2763615 | 0.88 | LMNA (0.47) | LMNAHSD17B10CYP3A4 | |
| SCHEMBL372921 | 0.84 | ALDH1A1 (0.31) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL149736 | 0.82 | ALDH1A1 (0.44) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL10357244 | 0.82 | ALDH1A1 (0.44) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL651493 | 0.81 | CYP2C19 (0.31) | — | |
| Ethylene Glycol SCHEMBL4257677 | 0.80 | — | — | |
| SCHEMBL3164849 | 0.79 | — | — | |
| SCHEMBL8850977 | 0.78 | — | — | |
| SCHEMBL65529 | 0.78 | TSHR (0.45) | LMNAHSD17B10ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3579965-B1 | POLYMER BEADS AND APPLICATION THEREOF | IXOM OPERATIONS PTY LTD (AU) | 2023-04-05 | — | — | EP | claimed |
| US-20200030786-A1 | POLYMER BEADS AND APPLICATION THEREOF | IXOM OPERATIONS PTY LTD (AU) | 2020-01-30 | — | — | US | claimed |
| US-10173197-B2 | Polymer beads incorporating solid particulate material | IXOM OPERATIONS PTY LTD (AU) | 2019-01-08 | — | — | US | claimed |
| WO-2018145152-A1 | POLYMER BEADS AND APPLICATION THEREOF | IXOM OPERATIONS PTY LTD (AU) | 2018-08-16 | — | — | WO | claimed |
| EP-2890734-B1 | POLYMER BEADS INCORPORATING SOLID PARTICULATE MATERIAL | IXOM OPERATIONS PTY LTD (AU) | 2018-02-28 | — | — | EP | claimed |
| US-20150218015-A1 | Polymer beads incorporating solid particulate material | CHEMICALS AUSTRALIA OPERATIONS PTY LTD (AU) | 2015-08-06 | — | — | US | claimed |
| EP-2890734-A1 | POLYMER BEADS INCORPORATING SOLID PARTICULATE MATERIAL | Chemicals Australia Operations Pty Ltd (AU) | 2015-07-08 | — | — | EP | claimed |
| WO-2014032092-A1 | POLYMER BEADS INCORPORATING SOLID PARTICULATE MATERIAL | ORICA AUSTRALIA PTY LTD (AU) | 2014-03-06 | — | — | WO | claimed |
| EP-0402466-B1 | PROCESS FOR PRODUCING METHACRYLIC RESIN MOLDING | KURARAY CO (JP) | 1995-05-03 | — | — | EP | claimed |
| US-5135981-A | Mar, weather adn heat resistance; polymerizing reaction product of methacryloyloxy silane and silica sol with crosslinking alkyl methacrylates til desired shape formed | KURARAY CO., LTD. (JP) | 1992-08-04 | — | — | US | claimed |
| EP-0402466-A1 | PROCESS FOR PRODUCING METHACRYLIC RESIN MOLDING | KURARAY CO., LTD. (JP) | 1990-12-19 | — | — | EP | claimed |
| US-12635688-B2 | Process and solution for preparing a surface with bacteriostatic and bactericidal activity, surface thus prepared and uses thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2026-05-26 | — | — | US | disclosed |
| US-20230180744-A1 | PROCESS AND SOLUTION FOR PREPARING A SURFACE WITH BACTERIOSTATIC AND BACTERICIDAL ACTIVITY, SURFACE THUS PREPARED AND USES THEREOF | INSTITUT NATIONAL DES SCIENCES ET INDUSTRIES DU VIVANT ET DE L'ENVIRONNEMENT (FR) | 2023-06-15 | — | — | US | disclosed |
| EP-3579965-B1 | POLYMER BEADS AND APPLICATION THEREOF | IXOM OPERATIONS PTY LTD (AU) | 2023-04-05 | — | — | EP | disclosed |
| EP-3522241-B1 | COMPOSITION FOR ORGANIC ELECTRONIC ELEMENT ENCAPSULANT, AND ENCAPSULANT FORMED USING SAME | MOMENTIVE PERFORMANCE MAT KOREA CO LTD (KR) | 2023-03-22 | — | — | EP | disclosed |
| US-5006415-A | Having abrasion resistant surface coating formed by placing partially crosslinked layer and base materials in contact and polymerizing during shaping | KYOWA GAS CHEMICAL INDUSTRY CO., LTD. (JP) | 1991-04-09 | — | — | US | disclosed |
| EP-0402466-A1 | PROCESS FOR PRODUCING METHACRYLIC RESIN MOLDING | KURARAY CO., LTD. (JP) | 1990-12-19 | — | — | EP | disclosed |
| US-4830803-A | ABRASION RESISTANCE | KYOWA GAS CHEMICAL INDUSTRY CO., LTD. (JP) | 1989-05-16 | — | — | US | disclosed |
| EP-0274808-A1 | Molded article of methacrylic resin and method for production thereof | Kuraray Co., Ltd. (JP) | 1988-07-20 | — | — | EP | disclosed |
| US-4414278-A | NONAGGLOMERATING, NONSWELLING | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230180744-A1 | PROCESS AND SOLUTION FOR PREPARING A SURFACE WITH BACTERIOSTATIC AND BACTERICIDAL ACTIVITY, SURFACE THUS PREPARED AND USES THEREOF | PCNA, LPO, CUTA | LMNA 904/4885HSD17B10 2576/4885ALDH1A1 3216/4885 |
| US-12635688-B2 | Process and solution for preparing a surface with bacteriostatic and bactericidal activity, surface thus prepared and uses thereof | LPO, C9, MSR1 | LMNA 153/4885HSD17B10 1519/4885ALDH1A1 1274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.